Global Active Pharmaceutical Ingredient (API) Market – Industry Trends and Forecast to 2031

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Active Pharmaceutical Ingredient (API) Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Reports
  • Apr 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Active Pharmaceutical Ingredient Api Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2024 –2031
Diagramm Marktgröße (Basisjahr)
USD 237.81 Million
Diagramm Marktgröße (Prognosejahr)
USD 393.58 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Novartis AG
  • Sanofi
  • Pfizer
  • Johnson & Johnson Private Limited
  • Abbott

Global Active Pharmaceutical Ingredient (API) Market, By Molecule (Small Molecule and Large Molecule), Type (Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, and Others), Type of Drug (Prescription Drugs and Over-the-Counter), Usage (Clinical and Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Other Therapeutic Application) – Industry Trends and Forecast to 2031.

Active Pharmaceutical Ingredient (API) Market

Active Pharmaceutical Ingredient (API) Market Analysis and Size

The active pharmaceutical ingredients (APIs) market is pivotal in providing the essential components for pharmaceutical formulations. In painkillers such as crocin and paracetamol API is the active ingredient responsible for alleviating pain. The demand for paracetamol remains high due to their widespread use of API drugs for pain relief. This drives growth in the API market, with manufacturers focusing on quality, efficiency, and compliance to meet global pharmaceutical standards.

Global active pharmaceutical ingredient (API) market size was valued at USD 237.81 million in 2023 and is projected to reach USD 393.58 million by 2031, with a CAGR of 6.50 % during the forecast period of 2024 to 2031. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis, and consumer behavior.  

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Molecule (Small Molecule and Large Molecule), Type (Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, and Others), Type of Drug (Prescription Drugs and Over-the-Counter), Usage (Clinical and Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Other Therapeutic Application)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Novartis AG (Switzerland), Sanofi (France), Pfizer Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Bausch Health Companies Inc. (Canada),), Sunovion Pharmaceuticals Inc. (U.S.), Jazz Pharmaceuticals, Inc. (U.K.), AstraZeneca (U.K.), GSK plc (U.K.), H. Lundbeck A/S (Denmark), Takeda Pharmaceutical Company Limited (Japan), Sumitomo Dainippon Pharma Co., Ltd. (Japan), and Cadila Pharmaceuticals (India) among others

Market Opportunities

  • Rising Geriatric Population Requiring Medication
  • Technological Advancements in API Production

Market Definition

Active pharmaceutical ingredients (APIs) are the primary components in medications responsible for their therapeutic effects. They are the biologically active substances that treat medical conditions. APIs can be synthetic or derived from natural sources and are formulated into various dosage forms such as tablets, capsules, or injections. Once ingested or administered APIs interact with the body to produce the desired therapeutic effect. They undergo stringent quality control measures to ensure the safety and efficacy of pharmaceutical products.

Active Pharmaceutical Ingredient (API) Market Dynamics

Drivers

  • Growing Demand for Pharmaceutical Products

As the global population grows and ages, the prevalence of various medical conditions rises, driving the need for medications. APIs serve as the essential components in drug formulations, making them indispensable in meeting this growing demand. Additionally, advancements in healthcare access and awareness further fuel the demand for APIs to develop and manufacture a wide range of pharmaceutical products. Thus, the increasing demand for pharmaceutical products acts as a major driver for the active pharmaceutical ingredients (APIS) market growth.

  • Increasing Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases worldwide for the active pharmaceutical ingredients (APIs) market. Conditions such as diabetes, cardiovascular diseases, and cancer are becoming more prevalent due to factors such as aging populations and lifestyle changes. APIs are vital components in the formulation of medications to manage chronic diseases, fueling demand for these ingredients. Consequently, active pharmaceutical ingredients manufacturers require a steady supply of APIs to meet the growing need for effective treatments, which is driving the market growth.

Opportunities

  • Rising Geriatric Population Requiring Medication

As people age, they typically require more medication to manage chronic conditions such as hypertension, arthritis, and dementia. APIs are essential components in formulating drugs for these ailments, driving demand for API production. With the elderly population projected to increase significantly in the coming years, pharmaceutical companies will increasingly rely on APIs to meet the growing demand for medications tailored to the needs of older adults. Thus, the rising geriatric population globally is a key driver for the active pharmaceutical ingredients (APIS) market growth.

  • Technological Advancements in API Production

Technological advancements in active pharmaceutical ingredient (API) production drive efficiency, quality, and innovation in the pharmaceutical industry. Improved manufacturing processes, such as continuous manufacturing and biocatalysis, enhance API yield and purity while reducing costs and environmental impact. Automation and data analytics optimize production workflows, leading to faster development and scale-up of API manufacturing. These advancements enable pharmaceutical companies to meet growing demand, develop complex APIs, and maintain competitiveness in the global market.

Restraints/Challenges

  • Pricing Pressures from Generic API Competitors

Pricing pressures from generic API competitors pose a significant challenge for the Active Pharmaceutical Ingredients (APIs) market. Generic API manufacturers often offer similar products at lower prices, intensifying competition and eroding profit margins for branded API producers. As a result, companies may struggle to maintain profitability and invest in research and development for new APIs. Additionally, pricing pressures may lead to cost-cutting measures that compromise quality or innovation, impacting the overall competitiveness of the API market.

  • Limited Availability of Raw Material

Many APIs rely on specific raw materials sourced from natural or synthetic origins, and disruptions in the supply chain can lead to shortages or price fluctuations. Factors such as environmental regulations, geopolitical tensions, and natural disasters can all impact the availability of raw materials, making it challenging for API manufacturers to maintain consistent production. This constraint can hinder the timely delivery of APIs to pharmaceutical companies, affecting drug manufacturing and ultimately patient access to medications. Hence, the limited availability of raw materials is a critical restraint in the active pharmaceutical ingredients (APIs) market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In 2022, Pfizer entered into an agreement with Acuitas to deliver a lipid nanoparticle delivery system for use in mRNA vaccines such as COMIRNATY (tozinameran) and therapeutics. This innovation facilitates wider adoption of mRNA therapeutics, propelling the active pharmaceutical ingredient market growth by providing more efficient and scalable delivery solutions for novel treatments
  • In 2022, Sanofi and IGM announced a strategic collaboration agreement to streamline and optimize the development and commercialization of IgM antibody agonists for oncology, immunology, and inflammation target. This collaboration accelerates the introduction of innovative treatments, expanding the pipeline of active pharmaceutical ingredients and fostering market growth by addressing unmet medical needs in oncology, immunology, and inflammation
  • In 2021, U.S. FDA approved a new drug by Teva Pharmaceutical and MEDinCell to treat schizophrenia. Furthermore, legal issues are decelerating the establishment of new API facilities.  This approval stimulates demand for Active Pharmaceutical Ingredients (APIs) used in its production

Active Pharmaceutical Ingredient (API) Market Scope

The market is segmented into eight notable segments based on molecule, type, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Molecule

  • Small Molecule
  • Large Molecule

 Type

  • Innovative Active Pharmaceutical Ingredients
  • Generic Innovative Active Pharmaceutical Ingredients

Type of Manufacturer

  • Captive API Manufacturer
  • Merchant API Manufacturer

Synthesis

  • Synthetic Active Pharmaceutical Ingredients
  • Biotech Active Pharmaceutical Ingredients

Chemical Synthesis

  • Acetaminophen
  • Artemisinin
  • Saxagliptin
  • Sodium Chloride
  • Ibuprofen
  • Losartan Potassium
  • Enoxaparin Sodium
  • Rufinamide
  • Naproxen
  • Tamoxifen
  • Others

Type of Drug

  • Prescription Drugs
  • Over-the-Counter

Usage

  • Clinical
  • Research

 Potency

  • Low-to-Moderate Potency Active Pharmaceutical Ingredients
  • Potent-to-Highly Potent Active Pharmaceutical Ingredient

Therapeutic Application

  • Cardiology
  • CNS and Neurology
  • Oncology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology Ophthalmology
  • Other Therapeutic Application

Active Pharmaceutical Ingredient (API) Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by based molecule, type, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is dominating the market because of the increasing healthcare expenditures and well-established healthcare infrastructure.

Asia-Pacific is expected to be the fastest-growing region in the market because of the increased consumption demand for active pharmaceutical ingredients.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2016-2021.

Competitive Landscape and Active Pharmaceutical Ingredient (API) Market Share Analysis

The market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

  • Novartis AG (Switzerland)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Abbott (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bausch Health Companies Inc. (Canada)
  • Sunovion Pharmaceuticals Inc. (U.S.)
  • Jazz Pharmaceuticals, Inc. (U.K.)
  • AstraZeneca (U.K.)
  • GSK plc (U.K.)
  • H. Lundbeck A/S (Denmark)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Cadila Pharmaceuticals (India)


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Global Active Pharmaceutical Ingredient (API) Market, By Molecule (Small Molecule and Large Molecule), Type (Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, and Others), Type of Drug (Prescription Drugs and Over-the-Counter), Usage (Clinical and Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Other Therapeutic Application) – Industry Trends and Forecast to 2031. .
The Global Active Pharmaceutical Ingredient Api Market size was valued at USD 237.81 USD Million in 2023.
The Global Active Pharmaceutical Ingredient Api Market is projected to grow at a CAGR of 6.5% during the forecast period of 2024 to 2031.
The major players operating in the market include , Novartis AG , Sanofi , Pfizer , Johnson & Johnson Private Limited , Abbott , Teva Pharmaceutical Industries , Bausch Health Companies , Sunovion Pharmaceuticals , Jazz Pharmaceuticals , AstraZeneca , GSK plc , H. Lundbeck A/S , Takeda Pharmaceutical Company Limited , Sumitomo Dainippon Pharma Co. , Cadila Pharmaceuticals among others ,.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.